Home  |  Contact

Cellosaurus WILL-2 (CVCL_1901)

[Text version]
Cell line name WILL-2
Synonyms WILL2
Accession CVCL_1901
Resource Identification Initiative To cite this cell line use: WILL-2 (RRID:CVCL_1901)
Comments Population: Japanese.
Doubling time: ~36-48 hours (DSMZ=ACC-652).
Omics: Transcriptome analysis by microarray.
Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
Disease Diffuse large B-cell lymphoma (NCIt: C8851)
Diffuse large B-cell lymphoma (ORDO: Orphanet_544)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 63Y
Category Cancer cell line
STR profile Source(s): DSMZ

Markers:
AmelogeninX
CSF1PO10,11
D2S133823,24
D3S135815,18
D5S8189,12
D7S82010,11
D8S117912,13
D13S3178,9
D16S5399,13
D18S5113,16
D19S43314,17
D21S1129,30
FGA19,21
Penta D11
Penta E5,14
TH016
TPOX11
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=19330555; DOI=10.1007/s12185-009-0295-4
Sonoki T., Li Y.-Q., Miyanishi S., Nakamine H., Hanaoka N., Matsuoka H., Mori I., Nakakuma H.
Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab.
Int. J. Hematol. 89:400-402(2009)

PubMed=26727417; DOI=10.3109/10428194.2015.1108414
Drexler H.G., Eberth S., Nagel S., MacLeod R.A.F.
Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas.
Leuk. Lymphoma 57:1015-1020(2016)

Cross-references
Cell line collections (Providers) DSMZ; ACC-652
Cell line databases/resources DSMZCellDive; ACC-652
Biological sample resources BioSample; SAMN03473465
Encyclopedic resources Wikidata; Q54994083
Gene expression databases GEO; GSM1374990
Entry history
Entry creation04-Apr-2012
Last entry update29-Jun-2023
Version number18